IL-18 production from the NLRP1 inflammasome prevents obesity and metabolic syndrome

Dragoljevic, D; Cengia, L; Vince, JE; Masters, SL; Lane, RM; Gerlic, M; Harrison, LC; Murphy, AJ; Lee, MK; Whitehead, LW; Kammoun, HL; Kile, BT; Vasanthakumar, A; Croker, BA; DiRago, L; Kraakman, MJ; Lawlor, KE; Metcalf, D; Febbraio, MA; Kallies, A; Wentworth, JM
Abstract
Interleukin-18 (IL-18) is activated by Caspase-1 in inflammasome complexes and has anti-obesity effects; however, it is not known which inflammasome regulates this process. We found that mice lacking the NLRP1 inflammasome phenocopy mice lacking IL-18, with spontaneous obesity due to intrinsic lipid accumulation. This is exacerbated when the mice are fed a high-fat diet (HFD) or a high-protein diet, but not when mice are fed a HFD with low energy density (high fiber). Furthermore, mice with an activating mutation in NLRP1, and hence increased IL-18, have decreased adiposity and are resistant to diet-induced metabolic dysfunction. Feeding these mice a HFD further increased plasma IL-18 concentrations and strikingly resulted in loss of adipose tissue mass and fatal cachexia, which could be prevented by genetic deletion of IL-18. Thus, NLRP1 is an innate immune sensor that functions in the context of metabolic stress to produce IL-18, preventing obesity and metabolic syndrome. Copyright © 2016 Elsevier Inc. All rights reserved.
Journal CELL METAB
ISSN 1550-4131
Published 12 Jan 2016
Volume 23
Issue 1
Pages 155-64
DOI 10.1016/j.cmet.2015.09.024
Type Journal Article
Sponsorship
NHMRC: 637367, 1002426, 1051210, 1057815, 461219, 363652, 1016647, 1085752 NHF: 100440